New HIV drug shows early promise in small study

NCT ID NCT07001319

Completed Disease control Sponsor: Gilead Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new experimental HIV medicine, GS-3242, in 27 people living with HIV-1. The goal was to see if the drug is safe and can lower the amount of virus in the blood over 11 days. Participants had not taken HIV medication for at least 12 weeks before the study. The results help researchers decide whether to continue developing this drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV-1-INFECTION

Contacts and locations

Locations

AIDS Healthcare Foundation - Northpoint

Fort Lauderdale, Florida, 33308, United States
AXCES Research Group, LLC

El Paso, Texas, 79902, United States
AXCES Research Group, LLC

Salt Lake City, Utah, 84102, United States
BLISS Health

Orlando, Florida, 32803, United States
Bamrasnaradura Infectious Diseases Institute

Nonthaburi, 11000, Thailand
Be Well Medical Center

Berkley, Michigan, 48072, United States
Central Texas Clinical Research

Austin, Texas, 78705, United States
Chatham County Health Department

Savannah, Georgia, 31401, United States
Faculty of Medicine Ramathibodi Hospital, Mahidol University

Bangkok, 10400, Thailand
Faculty of Medicine Siriraj Hospital, Mahidol University

Bangkok, 10700, Thailand
Franco Felizarta, MD

Bakersfield, California, 93301, United States
Indiana University School of Medicine

Indianapolis, Indiana, 46202, United States
Institute of HIV Research and Innovation (IHRI)

Bangkok, 10330, Thailand
KC CARE Health Center

Kansas City, Missouri, 64111, United States
Midland Florida Clinical Research Center, LLC

DeLand, Florida, 32720, United States
Midway Immunology & Research Center, LLC

Ft. Pierce, Florida, 34982, United States
Mills Clinical Research

Los Angeles, California, 90069, United States
North Texas Infectious Diseases Consultant's, P.A.

Dallas, Texas, 75246, United States
Orlando Immunology Center, PA

Orlando, Florida, 32803, United States
Prism Health North Texas

Dallas, Texas, 75208, United States
ProcliniQ Investigación Clínica S.A. de C.V

Mexico City, 6170, Mexico
Quest Clinical Research

San Francisco, California, 94115, United States
Ruane Clinical Research Group, Inc

Los Angeles, California, 90036, United States
Srinagarind Hospital, Faculty of Medicine, Khon Kaen University

Khon Kaen, 40002, Thailand
The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),Thai Red Cross AIDS and Infectious Disease Research Center

Pathumwan, 10330, Thailand
Triple O Research Institute, P.A.

West Palm Beach, Florida, 33407, United States
University of Cincinnati College of Medicine

Cincinnati, Ohio, 45267, United States
Washington Health Institute

Washington D.C., District of Columbia, 20017, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.